AVITA Therapeutics, Inc.
(NASDAQ : RCEL)

( )
RCEL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. -2.62%23.466.3%$1308.68m
TMOThermo Fisher Scientific, Inc. 1.72%386.771.0%$577.73m
MDTMedtronic Plc -0.04%91.630.6%$539.89m
DXCMDexCom, Inc. 2.17%435.118.2%$530.92m
BDXBecton, Dickinson & Co. 0.51%252.651.0%$511.29m
ABTAbbott Laboratories 0.13%92.580.8%$506.36m
DHRDanaher Corp. 1.30%184.410.7%$453.05m
BSXBoston Scientific Corp. -0.29%34.541.1%$428.78m
QDELQuidel Corp. 5.56%237.487.7%$402.17m
ISRGIntuitive Surgical, Inc. 0.98%580.962.4%$343.32m
SYKStryker Corp. 0.85%181.871.3%$315.38m
BAXBaxter International, Inc. -1.57%84.161.8%$276.48m
ALGNAlign Technology, Inc. 1.34%278.396.4%$244.82m
ZBHZimmer Biomet Holdings, Inc. 1.62%118.891.7%$211.46m
EWEdwards Lifesciences Corp. 0.25%68.740.4%$201.08m

Company Profile

AVITA Therapeutics, Inc., through its subsidiaries, engages in the development and and commercialization of medical devices used in regenerative medicine. The company is headquartered in Valencia, CA.